FDA Orange Book

Is there a generic for Alecensa?

Alecensa contains alectinib. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Alecensa (alectinib). The Orange Book shows its last listed patent expires April 24, 2035 and its last listed exclusivity ends April 18, 2031.

Run it in Rivvi

Map Alecensa and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Alecensa products in the Orange Book

Alecensa products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oralEQ 150MG BASEMarketed (Rx)None0None

NDA 208434, held by HOFFMANN-LA ROCHE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Alecensa patents

Patents listed for Alecensa
PatentExpiresCoversUse codeNDA
9440922June 9, 2030Drug productNone208434
9126931May 29, 2031Drug substanceNone208434
9365514March 4, 2032Drug productNone208434
10350214April 24, 2035Drug productNone208434
11433076April 24, 2035Drug productNone208434

Alecensa exclusivity

Exclusivity listed for Alecensa
CodeMeaningExpiresNDA
I-947New indicationApril 18, 2027208434
ODE-477Orphan drug exclusivityApril 18, 2031208434

Alecensa NDC codes

Questions

Is there a generic for Alecensa?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Alecensa (alectinib). The Orange Book shows its last listed patent expires April 24, 2035 and its last listed exclusivity ends April 18, 2031.

What is the generic name for Alecensa?

The active ingredient in Alecensa is alectinib, per the FDA Orange Book.

When does the Alecensa patent expire?

The last patent listed for Alecensa in the Orange Book expires April 24, 2035. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Alecensa and Alectinib

Try it on your own data today.

Free to start. Most teams are using it the same day.